The present study reviews the possible role of Se status during pregnancy regarding adverse pregnancy outcomes, with emphasis on those related to diminished antioxidant activity and increased oxidative stress. Studies have reported that Se could play an important role in adverse outcomes such as miscarriages, neural tube defects, diaphragmatic hernia, premature birth, low birth weight, pre-eclampsia, glucose intolerance and gestational diabetes. Also, low Se status has been associated with adverse outcomes among HIV-infected pregnant women and their offspring. Nevertheless, the function of Se in the aetiology of pregnancy complications is yet to be elucidated. Available evidence presents the following limitations: most study designs do not allow conclusions about causal relationships; study populations, selection of subjects, research setting, procedures for defining sample size and analytical methods are often poorly described; many studies fail to adjust for important confounding variables. In addition, population studies assessing the relationship between Se intake during pregnancy and health outcomes are scarce. Further research is still needed to clarify the role of Se status in adverse pregnancy outcomes, especially those related to augmented oxidative stress.
It is well recognised that maternal nutritional conditions during pregnancy can have a profound and long-lasting effect not only on women's health status but also on fetal, newborn and infant health, development and well-being (1 -3) .
During pregnancy, there can be a reduction in maternal Se concentrations, regardless of whether there are any gestational complications (4 -9) . Such reduction could be explained by haemodilution caused by maternal plasma expansion (10, 11) , or it could reflect transport of Se to the fetus (11) . It has also been hypothesised that during this period, higher amounts of Se are used for producing antioxidant compounds such as glutathione peroxidase (GPx) and selenoprotein P (12) .
Se, a mineral with well-known antioxidant activity that participates in the synthesis of selenoproteins, such as GPx, selenoprotein P and thioredoxin reductase, could have an important role in pregnancy, especially because oxidative stress might be increased during this period (13 -17) . Consequently, antioxidant defences have a central role in modulating events mediated by oxidative stress and could be related to perinatal morbidity and mortality (18 -22) .
In addition, an extensive body of literature has suggested that exacerbated oxidative stress during pregnancy plays an important role in many diseases and adverse pregnancy outcomes, which include miscarriages, pre-eclampsia, gestational diabetes, premature rupture of membranes and intra-uterine growth restriction (16,22 -31) .
Thus, the objective of the present review is to discuss the possible role of Se status during pregnancy regarding adverse pregnancy outcomes, with emphasis on those related to diminished antioxidant activity and increased oxidative stress.
Selenium status and adverse fetal and perinatal outcomes
Barrington et al. (32) observed significantly lower serum Se levels among women who had had a miscarriage in the first trimester of pregnancy than in either pregnant women or non-pregnant healthy volunteers. The authors referred that haemodilution cannot explain the difference in Se levels between these groups, considering that serum albumin and total protein concentrations of the pregnant and miscarried groups were not different. They suggested that low Se status in women with miscarriage could be related to membrane and cell DNA damage caused by loss of the antioxidant activity performed by Se.
Similar results were found by Al-Kunani et al. (33) , who described significantly lower hair Se concentrations in women with recurrent miscarriages when compared with non-pregnant women who had had successful pregnancies. In disagreement is the study carried out by Zachara et al. (34) , who observed no significant differences in whole-blood and plasma Se levels when comparing women with miscarriage against women with normal pregnancies. Nevertheless, these authors found that women with miscarriage had significantly lower erythrocyte and plasma GPx activities than women with normal pregnancies and non-pregnant women.
Reduced Se concentrations also seem to be related to neural tube defects, as reported in some studies. Güvenç et al. (35) observed low Se status in both mothers and their infants with neural tube defects and suggested that the occurrence of such defects could be related not only to a deficiency of the mineral, but also to inadequate intakes.
Although mechanisms implicated in the prevention of neural tube defects are still unknown, Martin et al. (36) suggested that in women with low Se status, low levels of folate could worsen oxidative stress, and thus purine and pyrimidine synthesis could be jeopardised.
Cengiz et al. (37) and Zeyrek et al. (38) assessed multiple micronutrients in mothers and their newborns with neural tube defects and found conflicting results regarding Se status. The first study found statistically significant lower maternal Se levels among cases. The second study, on the other hand, found that Se concentrations did not differ between cases and controls. It has also been reported in the literature that low Se intake could be associated with the occurrence of diaphragmatic hernia. Although this finding is supported by a large population-based case-control study (39) , the authors highlight limitations which include the use of a FFQ for the assessment of nutrient adequacy and the fact that maternal levels of nutrients were not measured. In addition, associations might have been exclusive to a particular nutrient or a consequence of highly correlated nutrients, and because of the elevated number of nutrients investigated, some might have shown statistically significant differences by chance. It is also possible that lack of information from non-participants might have biased the results.
Low Se status could also be related to adverse perinatal outcomes. It has been suggested that newborn Se concentrations may be related to the Se status of their mothers (30, 40, 41) , and that pre-term infants born to healthy women have lower Se concentrations than do term newborns (41 -44) . Such findings are not surprising since shortened gestations hinder appropriate transport of Se from the mother to the fetus. In fact, Al-Saleh et al. (42) emphasised that pre-term newborns can be at risk of Se deficiency, especially if total parenteral nutrition is needed. Moreover, as a consequence of their lower Se status, pre-term infants might have their antioxidant defences impaired, especially with respect to GPx activity, a Se-dependent enzyme, which may be related to higher incidence of oxygen dependence at 28 d of life (44, 45) . There are conflicting results, however, regarding the influence of gestational age on Se concentrations and erythrocyte GPx activity (30, 46, 47) .
Dobrzynski et al. (30) have considered a possible relationship between low Se status and premature birth, since pre-term parturient women in their study had lower plasma and blood Se concentrations than did term parturient women and healthy non-pregnant women. In their study, no significant correlations between gestational age and Se status measures were found. The authors also reported that preterm parturient women had significantly lower antioxidant status when compared with their controls, as indicated by their erythrocyte GPx activity. Nonetheless, this relationship is not supported by other studies (41, 47) .
With regard to the relationship between Se status and birth weight, there is still much disagreement in the literature. Although many studies have pointed to a possible association (11, 41, 42, 47, 48) , significant results varied according to the groups included or excluded from the analyses or the type of statistical tests applied. For instance, Iranpour et al. (41) observed only significant correlations between cord blood Se levels and birth weight when pre-term and term infants were considered together in the analysis; Al-Saleh et al. (42) found only a significant correlation between newborn Se concentrations and birth weight when low-birth-weight infants were included in the analysis; Kaplec et al. (48) found a significant correlation between placental Se concentrations and birth weight among newborns whose birth weight was appropriate for gestational age, but not among intra-uterine growth-restricted newborns; Bogden et al. (47) found no significant correlation between birth weight and serum Se as continuous variables, but a significant association was observed when the lowest decile of Se level was compared with the nine highest. In addition, many authors have failed to establish any kind of relationship between Se status and birth weight (30, 46, 49) . Bogden et al. (47) suggested that conflicting findings could be partly attributed to different timing in blood collection (i.e. early in pregnancy or at delivery), and that the effect of prematurity on birth weight could mask the association between Se levels and birth weight.
Concerning intra-uterine growth restriction, Zadrozna et al. (50) found increased Se concentrations in complicated placentas, suggesting a physiological response to maintain GPx activity due to augmented oxidative stress. On the other hand, Kaplec et al. (48) observed that Se levels were not predictors of intra-uterine growth restriction. Their findings are consistent with those of Llanos & Ronco (51) , who did not report statistically significant differences between 
CS Bydgoszcz, Poland
To determine whole-blood and plasma Se levels, erythrocyte glutathione concentrations and erythrocyte and plasma GPx activities in women with first-and second-trimester miscarriage Forty women with miscarriage (seventeen in the first trimester and twenty-three in the second trimester of pregnancy), thirty-six pregnant women and twenty-eight healthy age-matched non-pregnant women
Whole-blood and plasma mean Se levels were not statistically different between women who miscarried and women with normal pregnancies. There were statistically significant differences when both groups were compared with non-pregnant women (whole blood: P, 0·0001; plasma: P, 0·001). Erythrocyte and plasma GPx activities were significantly lower in women who miscarried when compared with both pregnant (P, 0·01 and 0·001, respectively) and non-pregnant women (P, 0·001 and 0·0001, respectively) Gü venç et al. (35) 
CS Elazig, Turkey
To investigate the relationship between maternal and neonatal Se status and the occurrence of NTD Twenty-eight newborns with NTD, thirty-two mothers and their newborns following healthy pregnancies, in addition to twenty healthy non-pregnant women Maternal serum and hair Se concentrations were significantly lower in those whose babies had NTD compared with women with normal pregnancies (P, 0·02) and healthy non-pregnant women (P, 0·001) Both serum and hair Se concentrations of infants with NTD were significantly lower than those of normal newborns (P, 0·01 and P, 0·001 for serum and hair concentrations, respectively) Martin et al. (36) CC
Palma de Mallorca, Spain
To determine aminothiol and Se status and to analyse thiolic status and amino acids involved in arginine synthesis in the case of Se depletion and repletion, investigating their association with the occurrence of NTD Forty-four women who had been pregnant with an NTD child (cases), and 181 women who had at least two healthy children, who had never taken periconceptional folic acid nor had prior history of congenital malformations, abortions and obstetric complication (controls)
The NTD group had significantly lower median serum Se levels compared with controls (P, 0·001) When compared with controls, women with depleted Se who had conceived fetuses with NTD had significantly higher plasma cysteine concentrations (P¼0·01), total cysteine: total homocysteine ratio (P, 0·001), glutathione (P¼0·005) and arginine concentrations (P¼0·004) Cengiz et al. (37) CC Ankara, Turkey
To assess maternal Zn, Se, Cu and Pb concentrations in women who had a second-trimester diagnosis of NTD Fourteen women whose pregnancies were terminated after a second-trimester diagnosis of NTD (cases) and fourteen age-, gravidity-and socioeconomic status-matched women with normal fetal outcome (controls) Serum Se levels were significantly lower in women whose babies had NTD when compared with women with normal pregnancies (P, 0·001). A statistically significant positive correlation was found between Zn and Se (r 0·676; P, 0·001) and a negative correlation between Zn, Se and Cu (r 2 425 and 2 0·443; P, 0·05) Zeyrek et al. (38) CC Sanliurfa, Turkey Although umbilical cord serum Se concentrations were significantly correlated with birth weight (r 0·237; P¼0·002) and 5 min Apgar score (r 0·202; P, 0·01), multiple regression analysis showed that only gestational age was significantly associated with umbilical cord serum Se concentration (P¼0·012). There was a significant negative correlation between maternal-umbilical Se difference and birth weight (r 2 0·369; P, 0·0001) and gestational age (r 2 0·337; P, 0·0001) Bodgen et al. (47) NCC Camden, NJ, USA To examine whether low dietary Se, low serum Se and/or low erythrocyte GPx in early pregnancy are predictors of fetal prematurity and low birth weight; to assess whether adverse effects of Se on pregnancy outcomes were related to thyroid function 107 Poor healthy pregnant women with pre-term delivery (, 37 weeks of gestation) were selected as cases. Among these, twenty-five women delivered very pre-term (, 32 completed weeks of gestation) and eighty-two delivered moderately pre-term ($ 32 to , 37 completed weeks of gestation). Controls were 126 women randomly selected from the 829 pregnant women who delivered at term assisted in the same clinics Serum Se concentrations did not differ between cases and controls. When pregnant women with Se concentrations in the lowest decile were compared with those with higher concentrations, lower Se in early pregnancy predicted lower birth weight for all subjects combined and for full-term controls (P¼0·01 and P¼0·02, respectively) Serum Se and erythrocyte GPx concentrations were not significantly different when subjects were categorised by gestational age at delivery, among other variables There were no significant differences in serum Se between women with gestational diabetes, pregnancy-induced hypertension or pre-eclampsia when compared with women without complications Klapec et al. (48) 
CS
Osijek, Croatia To investigate whether placental Se, Cd and Pb levels were related to fetal growth in a group of pregnancies with birth weight appropriate for gestational age and in a group of IUGR cases Placental samples collected from healthy mother -newborn pairs. Eighty-five samples were assessed: forty-nine IUGR and thirty-six appropriate-forgestational age births Placental Se content was associated with birth weight in the group whose birth weight was appropriate for gestational age (P, 0·05)
Odland et al. ( Se concentrations were significantly increased in IUGR and pre-term placentas compared with control placentas (P, 0·05). Such an increase could have increased GPx activity at a level comparable with control placentas normal-weight neonates and neonates with fetal growth restriction. The occurrence of adverse outcomes among infants born to HIV-infected mothers might be influenced by maternal Se status: low status has been associated with increased risks of fetal and child deaths, as well as intra-partum and breast-feeding transmission of HIV and lower risk of small-for-gestational age infants. Kupka et al. (52) have cited the role of Se in antioxidant defences as one of the factors that might be implicated in fetal deaths. Later, the same group conducted a randomised, double-blind, placebo-controlled trial of Se supplementation to HIV-infected pregnant women and found that the intervention reduced the risk of infant death after 6 weeks, although no significant effects were found regarding the risks of low birth weight, pre-term birth and small-for-gestational age (53) .
The main characteristics of studies assessing the relationship between Se status and the occurrence of adverse fetal outcomes are shown in Table 1 , whereas Table 2 summarises the characteristics of studies which investigated the relationship between Se status and adverse perinatal outcomes.
Selenium status and adverse maternal outcomes
There is evidence that maternal plasma Se concentrations are reduced in the presence of pre-eclampsia (54, 55) . Lower Se levels have been reported in the amniotic fluid of preeclamptic pregnant women compared with their normotensive controls (56) and infants born to pre-eclamptic women have shown lower umbilical cord blood Se levels than infants born to normotensive pregnant women (55) . Decreased GPx activity has also been observed in pre-eclamptic pregnancies (55) . Rayman et al. (57) suggested that Se deficiency before the onset of pre-eclampsia might be related to the incidence of the disease, although they speculated that the same association might not be found in populations with adequate Se status. Despite the body of evidence pointing to an association between Se status and pre-eclampsia, some studies have failed to find the same results (58 -60) .
Not only can serum Se levels be reduced in the presence of abnormal glucose metabolism and gestational diabetes (6, 61, 62) , but inadequate dietary Se intake has also been related to these conditions. Bo et al. (61) reported significantly lower Se intake in hyperglycaemic pregnant women, even after adjustment for confounders such as age, gestational age, familial diabetes, pre-pregnancy BMI and total energy intake. However, associations between maternal Se levels and outcomes such as the percentages of caesarean sections, small-or large-forgestational age newborns, pre-term births and neonatal morbidities have not been found. Taking these results into account, Kilinc et al. (62) suggested that Se status is important to glucose-intolerant individuals, and that its deficiency could aggravate diabetes and be related to complications in the gestational period. In addition, Bo et al. (61) proposed that dietary counselling and antioxidant supplementation might be useful if further research confirms the relationship between micronutrient status and hyperglycaemia.
Finally, low Se status of HIV-infected pregnant women has been related to increased risk of mortality, whereas high Se (52) L* Dar es Salaam, Tanzania To determine the association between Se status during pregnancy and pregnancy outcomes, mother-to-child transmission of HIV and child mortality 670 AIDS-free, HIV-infected pregnant women recruited between 12 and 27 weeks of gestation Low plasma Se levels were associated with increased risks of fetal death (P¼0·02), child death (P¼ 0·03) and HIV transmission through the intra-partum route (P¼ 0·03). Low Se status was not associated with risks of low birth weight (P¼0·22) or pre-term birth (P¼ 0·51) but was associated with an apparently lower risk of small-for-gestational age (P¼0·03) CS, cross-sectional; GPx, glutathione peroxidase; TPW, term parturient women; PPW, pre-term parturient women; NPW, non-pregnant women; TB, term babies; PB, pre-term babies; L*, longitudinal (including cohort and follow-up studies); ELBW, extremely low birth weight; NCC, nested case-control; IUGR, intra-uterine growth restriction. To assess and compare changes in serum Se concentrations in HPW, pregnant women with impaired glucose tolerance and GD along with their gestational period Ninety-eight pregnant women with impaired glucose tolerance, forty-six pregnant women with GD, ninety HPW and seventeen agematched healthy NPW Serum Se levels were significantly lower in HPW compared with NPW (P, 0·001). Women at more advanced gestational ages had lower serum Se levels for both normal and glucose intolerants and diabetic pregnant women (P, 0·05 for both groups). Both impaired glucose tolerance and GD groups had significantly lower serum Se concentrations compared with normal pregnant women and NPW (P, 0·001 for all comparisons) Atamer et al. (53) 
CS Diyarbakir, Turkey
To assess changes in erythrocyte superoxide dismutase, catalase and placental GPx activities; to measure serum malondialdehyde, Cu, Zn, Se, leptin and placental malondialdehyde and GSH Thirty-two pre-eclamptic pregnant women, twenty-eight HPW and twenty-five healthy NPW Serum Se levels were significantly lower in preeclamptic women compared with both HPW and NPW (P, 0·001). Placental GPx activity was significantly lower in pre-eclamptic women than in HPW (P, 0·001) Mistry et al. (54) CS Nottingham, UK To examine Se concentration and GPx expression and activity levels and markers of oxidative stress on maternal and umbilical venous blood samples or the placenta from HPW, pre-eclamptic women and healthy age-matched NPW Twenty-five white pre-eclamptic women, twenty-seven white HPW attending prenatal care and twenty-two white healthy agematched NPW There were significant trends for decreasing both plasma Se concentrations and plasma GPx activity from NPW to HPW and pre-eclamptic women (P, 0·001) Umbilical venous Se concentrations and plasma GPx activity were also significantly reduced in the samples from babies born to pre-eclamptic mothers when compared with the ones born to normotensive mothers (P, 0·005 and P, 0·02, respectively). Reduced placental GPx activity was observed in pre-eclampsia placenta compared with normal pregnancy (P, 0·001) Dawson et al. (55) CS Galveston, TX, USA
To determine changes in metal levels in third-trimester amniotic fluid and changes in metal levels associated with pre-eclampsia 130 Amniotic fluid samples collected from forty-eight normal and ten pre-eclamptic pregnant women between 33 and 36 weeks of gestation and from fifty-three normal and nineteen pre-eclamptic pregnant women from 37 to 40 weeks of gestation Se levels were 30 % lower in the presence of preeclampsia in early third-trimester pregnancies (P, 0·02). However, no significant difference was found for late third-trimester pregnancies Rayman et al. (56) CC Oxford, UK To investigate the association between low Se status and increased risk of pre-eclampsia Fifty-three pre-eclamptic obstetric patients and fifty-three pregnant controls Pre-eclamptic women had significantly lower median Se concentrations compared with their controls (P, 0·001). Women in the bottom tertile of toenail Se levels had a greater incidence of pre-eclampsia (OR 4·4, 95 % CI 1·6, 14·9). Pre-eclamptic women who gave birth before 32 weeks of gestation had significantly lower Se status than those who delivered after 32 weeks (P¼0·029) Roy et al. (57) CS Singapore To assess amniotic fluid Se levels in pre-eclamptic women and in HPW Amniotic fluid samples from forty pre-eclamptic women between 34 and 42 weeks of gestation and amniotic fluid samples from sixty HPW Amniotic fluid Se levels did not differ significantly between HPW and pre-eclamptic pregnancies status has been associated with higher CD4 cell count in the first years of follow-up in the cohort study by Kupka et al. (63) . However, in the Se supplementation study conducted by the same group and previously cited in the present paper, the intervention had no statistically significant effects on CD4, CD8 and CD3 cell counts, viral load or maternal mortality (53) .
The main characteristics of studies assessing the relationship between low Se status and adverse maternal outcomes are presented in Table 3 .
Limitations of available evidence
It must be emphasised that the role of Se status in the aetiology of pregnancy complications is yet to be established. Although a connection between low Se status and the occurrence of adverse fetal outcomes has been suggested, because most available studies are cross-sectional or case -control, their results are not appropriate to the assessment of causal relationships. Thus, low Se status could either be implicated in the causal process of such adverse outcomes or simply indicate a maternal physiological response to increased oxidative stress states. Ideally, high-quality prospective studies assessing the Se status of women through the periconceptional period to pregnancy loss or detection of any adverse outcome should be carried out, but such type of design is not always feasible.
Additionally, some studies have limitations that should be noted and addressed in future research, which comprise a comprehensive description of study populations (including their Se status), selection of subjects, research setting and analytical methods poorly described. The lack of such type of information limits generalisation of study results. Also, most studies fail to present the procedures for defining sample sizes, thus making it difficult to judge their statistical power, especially because many studies have small sample sizes.
Among important confounding variables, which should be taken into account but are not frequently assessed, are maternal Se intake, parity and smoking habits. Maternal nutrient intake assessment as a whole is essential since it can also be hypothesised that Se-deficient women lack other micronutrients, and thus Se deficiency itself might not explain adverse fetal outcomes. Indeed, Bogden et al. (47) suggested that the association between serum Se and birth weight in neonates could simply reflect good maternal nutritional status. Parity could contribute not only to low Se status but also to other micronutrient deficiencies, which could also influence pregnancy outcomes. Smoking should also be included in the analyses since it induces oxidative stress and consequently activates antioxidant defence mechanisms (11, 47) . In addition, cigarettes might contain Se, which could also interfere in maternal Se status. Bogden et al. (47) highlighted the fact that most studies do not control for this variable, which can hinder possible associations between Se measurements and pregnancy outcomes.
Finally, even though there is evidence suggesting that Se status might be important in relation to the occurrence of gestational morbidities, large representative population studies assessing the relationship between Se intake during pregnancy and maternal and newborn health outcomes are still scarce.
Conclusion
Although Se status might play an important role in adverse pregnancy outcomes, probably because of its participation in the antioxidant defence system as GPx, not enough evidence has been produced so far to form a comprehensive understanding of the role of Se. Further research with bigger sample sizes, prospective designs and well-documented reports are still needed, allowing greater statistical power and more robust analyses. Ideally, maternal Se and antioxidant status should be assessed from periconceptional through postnatal periods, and a large array of maternal and newborn outcomes should be addressed. Moreover, studies evaluating the relationship between dietary and supplementary Se intake before and during pregnancy in relation to adverse outcomes would be of great importance.
